Convalescent plasma for treatment of COVID-19: study protocol for an open randomised controlled trial in Sweden

INTRODUCTION: Although there are many studies on the use of convalescent plasma (CP) for treatment of COVID-19, it is not clear (1) which groups of patients may benefit, (2) what dose of plasma to give, or (3) which antibody levels the plasma should contain. Previous phase I/II studies and literatur...

Descripción completa

Detalles Bibliográficos
Autores principales: Dillner, Joakim, Ursing, Johan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Infectious Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8655340/
https://www.ncbi.nlm.nih.gov/pubmed/34880010
http://dx.doi.org/10.1136/bmjopen-2020-048337

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8655340/
https://www.ncbi.nlm.nih.gov/pubmed/34880010
http://dx.doi.org/10.1136/bmjopen-2020-048337

Ejemplares similares